Androgen Deprivation Therapy for Advanced Prostate Cancer: Can Evolution Be Accelerated?

被引：1
|
作者：
Mohler, James L. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
机构：
[1] Roswell Pk Canc Inst, Translat Res, Buffalo, NY 14263 USA
[2] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA
[3] Roswell Pk Canc Inst, Prostate Program, Buffalo, NY 14263 USA
[4] Roswell Pk Canc Inst, Oncol, Buffalo, NY 14263 USA
[5] Univ Buffalo, Urol, Sch Med & Biomed Sci, Buffalo, NY USA
[6] Univ N Carolina, Urol, Chapel Hill, NC 27515 USA
[7] Johns Hopkins Univ, Sch Med, Urol Oncol, Baltimore, MD 21218 USA
[8] NCCN Guidelines Panel Prostate Canc, Buffalo, NY USA
来源：
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2016年 / 14卷 / 06期
关键词：
PELVIC LYMPHADENECTOMY; RADICAL PROSTATECTOMY; INTERMITTENT; IMMEDIATE;
D O I：
10.6004/jnccn.2016.0071
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：701 / 703
页数：3
相关论文
共 50 条
  • [21] Current Approach to Androgen Deprivation Therapy in Patients With Advanced Prostate Cancer
    Heidenreich, Axel
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (11) : 776 - 781
  • [22] Cognitive Effects of Androgen Deprivation Therapy in Men With Advanced Prostate Cancer
    Gunlusoy, Bulent
    Ceylan, Yasin
    Koskderelioglu, Asli
    Gedizlioglu, Muhtesem
    Degirmenci, Tansu
    Ortan, Pinar
    Kozacioglu, Zafer
    UROLOGY, 2017, 103 : 167 - 171
  • [23] Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer
    Perera, Marlon
    Roberts, Matthew J.
    Klotz, Laurence
    Higano, Celestia S.
    Papa, Nathan
    Sengupta, Shomik
    Bolton, Damien
    Lawrentschuk, Nathan
    NATURE REVIEWS UROLOGY, 2020, 17 (08) : 469 - 481
  • [24] Germline Predictors of Androgen Deprivation Therapy Response in Advanced Prostate Cancer
    Kohli, Manish
    Riska, Shaun M.
    Mahoney, Douglas W.
    Chai, High S.
    Hillman, David W.
    Rider, David N.
    Costello, Brian A.
    Qin, Rui
    Lamba, Jatinder
    Sahasrabudhe, Deepak M.
    Cerhan, James R.
    MAYO CLINIC PROCEEDINGS, 2012, 87 (03) : 240 - 246
  • [25] Intermittent Versus Continuous Androgen Deprivation Therapy in Advanced Prostate Cancer
    Laurence Klotz
    Current Urology Reports, 2013, 14 : 159 - 167
  • [26] Androgen deprivation therapy with Leuprolide acetate for treatment of advanced prostate cancer
    Hoda, M. Raschid
    Kramer, Mario W.
    Merseburger, Axel S.
    Cronauer, Marcus V.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (01) : 105 - 113
  • [27] Androgen deprivation therapy in advanced prostate cancer. Multicenter study
    Jose Valencia-Guadalajara, Victor
    Martinez-Cayuelas, Laura
    Sarrio-Sanz, Pau
    Sanchez-Caballero, Laura
    Polo-Hernandez, Rebeca
    Silvia Chillon-Sempere, Francisca
    Antonio Galan-Llopis, Juan
    Garces-Valverde, Marina
    Antonio Tenza-Tenza, Jose
    Costa-Martinez, Asuncion
    Garcia Serrado-Paumard, Diego
    Escudero-Fontana, Eva
    Tello-Royloa, Carlos
    Patricia Verdu-Verdu, Lidia
    Fernando Bravo-Lopez, Diego
    Perez Seoane-Ballester, Helena
    Jose Pacheco-Bru, Juan
    Angel Ortiz-Gorraiz, Manuel
    ARCHIVOS ESPANOLES DE UROLOGIA, 2020, 73 (06): : 499 - 508
  • [28] Androgen deprivation therapy for advanced prostate cancer: why does it fail and can its effects be prolonged?
    Singer, Eric A.
    Golijanin, Dragan J.
    Messing, Edward M.
    CANADIAN JOURNAL OF UROLOGY, 2008, 15 (06) : 4381 - 4387
  • [29] Intermittent androgen deprivation in advanced prostate cancer
    T. M. de Reijke
    Urological Research, 1997, 25 : S63 - S66
  • [30] Intermittent androgen deprivation in advanced prostate cancer
    deReijke, TM
    UROLOGICAL RESEARCH, 1997, 25 (Suppl 2): : S63 - S66
12345